# The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US

Study · id `cardio:ct-nct06700239` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06700239](<https://clinicaltrials.gov/study/NCT06700239>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06700239

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.

## Technical summary

Registry record NCT06700239. Randomized; single masking; primary purpose treatment. Start 2025-12-31 (anticipated); primary completion 2027-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT06700239, source copy `cardio:ctgov-nct06700239-2025-11-26`, retrieved 2026-10-26)
- Planned start: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT06700239, source copy `cardio:ctgov-nct06700239-2025-11-26`, retrieved 2026-10-26)
- Primary completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT06700239, source copy `cardio:ctgov-nct06700239-2025-11-26`, retrieved 2026-10-26)
- Completion: 2032-12 (anticipated) (ClinicalTrials.gov record NCT06700239, source copy `cardio:ctgov-nct06700239-2025-11-26`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06700239-2025-11-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US
- Acronym: STTAR-US
- Condition: Tricuspid Regurgitation Functional
- Condition: Tricuspid Regurgitation
- Condition: Severe Tricuspid Valve Regurgitation
- Intervention (Device): MIA\_T Device
- Lead sponsor: Micro Interventional Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Tricuspid regurgitation (`cardio:tricuspid-regurgitation`)

## Provenance

Content hash: d69db4cfc426a6b4da0e2db790f2e78ceff7953ed9c519c30c2d6f338ab369e9
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
